62 related articles for article (PubMed ID: 17662495)
1. Carbohydrate antigen 125 for mortality risk prediction following acute myocardial infarction.
Falcão F; Oliveira F; Cantarelli F; Cantarelli R; Brito Júnior P; Lemos H; Silva P; Camboim I; Freire MC; Carvalho O; Sobral Filho DC
Sci Rep; 2020 Jul; 10(1):11016. PubMed ID: 32620821
[TBL] [Abstract][Full Text] [Related]
2. Association of Cancer Antigen 125 with Long-Term Prognosis in Light-Chain Cardiorenal Amyloidosis.
Wu B; Shi J; Yu F; Wu Y; Tao X; Xuan T; Yang J; Wang X
Cardiorenal Med; 2023; 13(1):19-25. PubMed ID: 36215974
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate antigen 125 in congestive heart failure: ready for clinical application?
Feng R; Zhang Z; Fan Q
Front Oncol; 2023; 13():1161723. PubMed ID: 38023127
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide and N-terminal Pro-B-type natriuretic peptide in severe aortic stenosis: a comprehensive literature review.
Cavalcante PN; Kanhouche G; Rosa VEE; Campos CM; Lopes MP; Lopes MAAAM; Sampaio RO; de Brito Júnior FS; Tarasoutchi F; Abizaid AAC
Front Cardiovasc Med; 2023; 10():1182530. PubMed ID: 37727304
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers Associated with Mortality in Aortic Stenosis: A Systematic Review and Meta-Analysis.
White M; Baral R; Ryding A; Tsampasian V; Ravindrarajah T; Garg P; Koskinas KC; Clark A; Vassiliou VS
Med Sci (Basel); 2021 May; 9(2):. PubMed ID: 34067808
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure.
Yoon JY; Yang DH; Cho HJ; Kim NK; Kim CY; Son J; Roh JH; Jang SY; Bae MH; Lee JH; Park HS; Cho Y; Chae SC
Korean J Intern Med; 2019 Jul; 34(4):811-818. PubMed ID: 30616330
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of Serum Biomarkers of Cardiac Stress in Aortic Stenosis.
Patel N; Kumbhani DJ
Curr Heart Fail Rep; 2018 Oct; 15(5):281-286. PubMed ID: 30062624
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of CA125 and NT-proBNP values in patients undergoing transcatheter aortic valve implantation.
Ayhan H; Kasapkara HA; Durmaz T; Keleş T; Sarı C; Baştuğ S; Erdoğan KE; Bayram NA; Bilen E; Akçay M; Bozkurt E
J Geriatr Cardiol; 2015 Mar; 12(2):100-6. PubMed ID: 25870611
[TBL] [Abstract][Full Text] [Related]
9. Higher carbohydrate antigen 125 levels are associated with increased risk of coronary heart disease in elderly chinese: a population-based case-control study.
Li X; He M; Zhu J; Yao P; Li X; Yuan J; Min X; Lang M; Yang H; Hu FB; Wu T; Wei S
PLoS One; 2013; 8(11):e81328. PubMed ID: 24303042
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of antigen carbohydrate 125 in heart failure.
Núñez J; Miñana G; Núñez E; Chorro FJ; Bodí V; Sanchis J
Heart Fail Rev; 2014 Sep; 19(5):575-84. PubMed ID: 23925386
[TBL] [Abstract][Full Text] [Related]
11. Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement.
Pfister R; Wahlers T; Baer FM; Scherner M; Strauch J; Erdmann E
Clin Res Cardiol; 2010 May; 99(5):301-7. PubMed ID: 20140438
[TBL] [Abstract][Full Text] [Related]
12. Natriuretic peptides in the management of aortic stenosis.
Bergler-Klein J
Curr Cardiol Rep; 2009 Mar; 11(2):85-93. PubMed ID: 19236823
[TBL] [Abstract][Full Text] [Related]
13. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
[TBL] [Abstract][Full Text] [Related]
15. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide.
Lim P; Monin JL; Monchi M; Garot J; Pasquet A; Hittinger L; Vanoverschelde JL; Carayon A; Gueret P
Eur Heart J; 2004 Nov; 25(22):2048-53. PubMed ID: 15541842
[TBL] [Abstract][Full Text] [Related]
16. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
[TBL] [Abstract][Full Text] [Related]
17. [Use of brain natriuretic peptide (BNP) in the diagnosis and treatment of heart failure].
Martin-Du Pan RC; Ricou F
Rev Med Suisse Romande; 2003 Feb; 123(2):125-8. PubMed ID: 15095695
[TBL] [Abstract][Full Text] [Related]
18. Cardiac troponin levels in heart failure.
Potluri S; Ventura HO; Mulumudi M; Mehra MR
Cardiol Rev; 2004; 12(1):21-5. PubMed ID: 14667259
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
